OMGAOmega Therapeutics, Inc.

Nasdaq omegatherapeutics.com


$ 1.95 $ -0.21 (-9.68 %)    

Friday, 10-May-2024 15:59:55 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 1.96
$ 2.09
$ 0.00 x 0
$ 0.00 x 0
$ 1.95 - $ 2.10
$ 1.30 - $ 10.09
519,333
na
108.09M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 09-10-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 chardan-capital-maintains-buy-on-omega-therapeutics-maintains-7-price-target

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $7 price target.

 omega-therapeutics-q1-2024-gaap-eps-036-misses-035-estimate-sales-2360m-beat-1630m-estimate

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of ...

 hc-wainwright--co-reiterates-buy-on-omega-therapeutics-maintains-12-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Omega Therapeutics (NASDAQ:OMGA) with a Buy and maintains $12 price ...

 omega-therapeutics-presents-new-preclinical-data-supporting-the-potential-of-precision-epigenomic-control-at-aacr-2024

MYC-directed epigenomic controller exerts anti-tumor effect in preclinical models of EGFR inhibitor-resistant NSCLC regardles...

 piper-sandler-reiterates-overweight-on-omega-therapeutics-lowers-price-target-to-9

Piper Sandler analyst Edward Tenthoff reiterates Omega Therapeutics (NASDAQ:OMGA) with a Overweight and lowers the price tar...

 chardan-capital-maintains-buy-on-omega-therapeutics-lowers-price-target-to-7

Chardan Capital analyst Keay Nakae maintains Omega Therapeutics (NASDAQ:OMGA) with a Buy and lowers the price target from $1...

 omega-therapeutics-q4-2023-gaap-eps-037-beats-047-estimate

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(...

 why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Applied Therapeutics, Inc.

 crude-oil-moves-lower-walgreens-posts-upbeat-earnings

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow trad...

 wedbush-reiterates-outperform-on-omega-therapeutics-maintains-12-price-target

Wedbush analyst Robert Driscoll reiterates Omega Therapeutics (NASDAQ:OMGA) with a Outperform and maintains $12 price target.

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 dow-surges-200-points-us-services-pmi-edges-higher-in-december

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The D...

 famed-obesity-drug-maker-novo-nordisk-inks-collaborations-for-cardiometabolic-diseases

Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.

 lamb-weston-posts-upbeat-results-joins-omega-therapeutics-allstate-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdin...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION